| __timestamp | Axsome Therapeutics, Inc. | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 347523000 |
| Thursday, January 1, 2015 | 6776987 | 479514000 |
| Friday, January 1, 2016 | 21199860 | 581861000 |
| Sunday, January 1, 2017 | 19957616 | 1326361000 |
| Monday, January 1, 2018 | 23495055 | 1197957000 |
| Tuesday, January 1, 2019 | 53647067 | 1154111000 |
| Wednesday, January 1, 2020 | 70244579 | 2215942000 |
| Friday, January 1, 2021 | 58060725 | 1458179000 |
| Saturday, January 1, 2022 | 57947447 | 1585936000 |
| Sunday, January 1, 2023 | 97944000 | 1627594000 |
| Monday, January 1, 2024 | 187077000 | 2606848000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Incyte Corporation and Axsome Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Incyte Corporation consistently outpaced Axsome Therapeutics, with R&D expenses peaking at approximately $1.63 billion in 2023, a staggering 370% increase from 2014. In contrast, Axsome's R&D spending, while more modest, showed a significant upward trend, culminating in a 2,190% increase over the same period, reaching nearly $98 million in 2023.
These figures highlight the dynamic nature of the biotech industry, where strategic R&D investments can drive innovation and growth. As these companies continue to push the boundaries of medical science, their R&D spending will remain a key metric to watch.
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Axsome Therapeutics, Inc.
BeiGene, Ltd. vs Incyte Corporation: Strategic Focus on R&D Spending
R&D Spending Showdown: Genmab A/S vs Axsome Therapeutics, Inc.
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
R&D Insights: How Incyte Corporation and Amneal Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Incyte Corporation or Vericel Corporation: Who Invests More in Innovation?
R&D Spending Showdown: Incyte Corporation vs Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Incyte Corporation and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.